SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-006952
Filing Date
2022-01-24
Accepted
2022-01-24 16:48:35
Documents
2
Period of Report
2022-01-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm223246-13_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm223246-13_3seq1.xml 3 10181
2 EXHIBIT 24 tm223246d13_ex24.htm EX-24 8421
  Complete submission text file 0001104659-22-006952.txt   20097
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Issuer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GELESIS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address
Sannino Alessandro (Reporting) CIK: 0001895699 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39362 | Film No.: 22550005